← Human Trials & Peer-Reviewed Studies
Effects of Nifedipine and Labetalol Combined with Magnesium Sulfate on Blood Pressure Control, Blood Coagulation Function, and Maternal and Infant Outcome in Patients with Pregnancy-Induced Hypertension.
Plain-language guide to PMID 36277012 (2022): randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 2021, participants, low blood pressure and orthostatic hypotension.
Key Facts
- PMID
- 36277012
- Journal
- Computational and mathematical methods in medicine
- Year
- 2022
- Study type
- Randomized Controlled Trial
- Authors
- Shao Y et al. (3 authors)
- DOI
- 10.1155/2022/9317114
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Vitamin D, K2, Magnesium and Zinc in the context of low blood pressure and orthostatic hypotension, published as a randomized controlled trial.
The purpose is to investigate the influence of nifedipine, labetalol, and magnesium sulfate on blood pressure control, blood coagulation, and maternal and infant outcome in those suffering from pregnancy-induced hypertension (PIH).
Who Took Part
The abstract describes 2021, participants taking part.
PubMed tags the participants as women only.
From January 2019 to April 2021, 100 participants with PIH in their center were randomly assigned to a control group and a research group.
How the Study Was Run
In design terms this was a randomized study.
Random assignment meant chance, not the researchers, decided who got Vitamin D, K2, Magnesium and Zinc and who got the comparison, which limits bias.
As a control, nifedipine combined with magnesium sulfate was administered.
Nifedipine, labetalol, and magnesium sulfate were administered to the research group.
The curative effect, blood pressure level, blood coagulation function, vascular endothelial function, and pregnancy comparisons were made between the two groups.
What Was Measured
Topics PubMed links to this paper include Labetalol, Nifedipine, Hypertension, Pregnancy-Induced, Blood Pressure, Magnesium Sulfate, Antihypertensive Agents and Placenta.
What This Means in Plain Language
The paper is a randomized study of Vitamin D, K2, Magnesium and Zinc in 2021, participants in people with low blood pressure and orthostatic hypotension.
With several hundred people or more, it is a fairly large study for this kind of research.
Its findings take up roughly 11 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2022 (Computational and mathematical methods in medicine), a journal based in United States.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, Low blood pressure and orthostatic hypotension research.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
- Low blood pressure and orthostatic hypotension research
- Vitamin D, K2, Magnesium and Zinc in the library
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.